ARS Pharmaceuticals, Inc.SPRYNASDAQ
Loading
Gross Margin Over TimeStrong
Percentile Rank43
3Y CAGR-8.8%
5Y CAGR+29.1%
Studio
Year-over-Year Change

Gross profit as a percentage of revenue

3Y CAGR
-8.8%/yr
Annual compound
5Y CAGR
+29.1%/yr
Recent deceleration
Percentile
P43
Within normal range
vs 5Y Ago
3.6x
Strong expansion
Streak
2 yr
Consecutive declineStrong
PeriodValueYoY Change
TTM75.77%-1.5%
202476.94%-23.1%
2023100.00%0.0%
2022100.00%+4.0%
202196.13%+355.4%
202021.11%-
20190.00%-
20180.00%-